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A report on Genome Informatics 2014, held in
Cambridge, UK, 21-24 September, 2014.function of the disrupted genes.The first time I attended Genome Informatics was in
2010. The content of the talks and posters reflected a field
that was still coming to terms with the era of short read
sequencing. Many presentations were devoted to the ana-
lytical challenges of working with high-throughput se-
quencing data; assembly, alignment, variant calling and
data storage were frequent topics both formally from
the podium and informally in the hallways. The latest
Genome Informatics meeting, held at Churchill College
in Cambridge, UK, 21-24 September 2014, highlighted
just how far the field has come in only a few years. The
focus of the meeting is shifting towards the challenges
of applying sequencing at all scales - from individual
cells to populations - in all areas of biology. To demon-
strate the diverse state of the field, I highlight represen-
tative talks from this year’s Genome Informatics
conference below.Personal and medical genomics
The meeting opened with a series of talks on Personal
and Medical Genomics. Atul Butte (Stanford University,
USA) gave an overview of his work in translating bio-
medical discoveries into clinical use. Butte highlighted
the value in mining published scientific literature for in-
formation on SNPs, phenotypes and diseases but pointed
out that the information is often incomplete or conflict-
ing between reports. The difficulty of using incomplete
and occasionally inaccurate publications to predict the
effect of sequence variation was reiterated by Elizabeth
Worthey (Medical College of Wisconsin, USA) later in
the session, who reported on her experiences using se-
quencing to diagnose pediatric disease.
Konrad Karczewski (Massachusetts General Hospital,
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months following its publication. After this tim
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creativecommons.org/publicdomain/zero/1.0/(LoF) variation can be thought of as naturally occurring
‘knockout experiments’. Karczewski described analysis
tools to improve the quality of LoF variant calls and how
large sequenced cohorts can be mined to reveal the
In recent years there have been many notable success
stories in using sequencing to diagnose rare Mendelian
diseases. Often though, multiple cases are needed to pin
down the causative variant. Orion Buske (The Hospital
for Sick Children and the University of Toronto,
Canada) presented PhenomeCentral, a system to match
individuals afflicted with a rare disease by phenotypic
similarity. This work relies on the development of a rich
ontology to describe the clinical manifestation of a disease,
a topic that was addressed by Peter Robinson (Charité-
Universitätsmedizin Berlin, Germany) later in the week.
Whole genome sequencing is increasingly being used to
guide personalized therapy for cancer patients with ad-
vanced malignancies. Yaoqing Shen (Genome Sciences
Centre, BCCA, Canada) described a project to sequence
the genome and transcriptome of cancer patients, which
are mined for potential therapeutic interventions. Shen in-
dicated that the project is now entering a second phase
with plans to analyze the genomes of 5,000 patients.RNA, the non-coding genome and epigenomics
Two sessions addressed how sequencing the genome,
transcriptome and epigenome can be used to better
understand the cell’s regulatory machinery and interpret
genomic function. For common diseases, large genome-
wide association studies uncover dozens to hundreds of
risk loci. Davis McCarthy (University of Oxford, UK) is
using whole genome sequencing data to assess the con-
tribution of different variant classes to variance in type 2
diabetes liability. McCarthy’s work indicates a substantial
proportion of variance in liability is explained by variants
in enhancers, which tissue-based analysis shows is driven
by enhancers active in pancreatic islet cells.
Rafael Irizarry (Harvard University, USA) provided strik-
ing examples of how confounding variables can distort
the interpretation of RNA-Seq and methylation studies.
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experiments. Michael Hoffman (Princess Margaret Cancer
Centre, Canada) described analysis tools for cytosine
methylation data sets, including methods to integrate re-
sults across multiple experiments and predict the effect of
methylation on transcription factor binding.
Roderic Guigo (Centre for Genomic Regulation, Spain)
delivered one of the conference’s keynote lectures. Guigo
discussed early findings from the Genotype-Tissue
Expression project (GTEx), which explores transcrip-
tional variation across tissues and individuals. The pro-
ject includes data from hundreds of individuals and
thousands of RNA-Seq samples, which reveal patterns of
tissue-specific expression and splicing. Interpreting hu-
man transcriptomes was also the subject of talks by
Tuuli Lappalainen (New York Genome Center, USA)
and Stephen Montgomery (Stanford University, USA).
Lappalainen described her work characterizing nonsense-
mediated decay and parental imprinting leading to mono-
allelic expression. Montgomery used transcriptome
sequencing of a large family to assess the role of rare
non-coding variants in the regulation of gene expres-
sion and splicing.
Single cell RNA-Seq provides unprecedented reso-
lution of transcriptional heterogeneity. John Marioni
(European Bioinformatics Institute, UK) demonstrated
that single cell expression data could be mapped into a
spatial context by first building a ‘gene expression atlas’
using in situ hybridization of a small number of markers.
Maroni used this technique to explore expression patterns
in the brain of Platynereis dumerilii.Algorithms, data structures and databases
A recurring algorithmic topic at the meeting was develop-
ing methods that operate on populations. This was best
exemplified by Ryan Layer’s talk (University of Virginia,
USA), which described a compression-based system for ef-
ficiently storing and querying genotypes for millions of
samples. Zamin Iqbal (University of Oxford, UK) and I de-
scribed how assembly graphs can be used to explore and
catalog sequence variation in pathogens, human popula-
tions and cancers. Jean Monlong (McGill University,
Canada) is using patterns of sequence variation across hu-
man populations to improve the resolution of structural
variation detection.
Serafim Batzoglu (Stanford University, USA) delivered
a keynote discussing fast methods for detecting identity-
by-descent in large cohorts and improvements to variant
calling and imputation methods for low-coverage se-
quencing of populations. Batzoglou also presented algo-
rithms for reconstructing tumor lineages in cancer and
methods to phase sequence variants using barcoded
pools of long DNA fragments.The human reference genome has expanded to incorp-
orate additional haplotypes and novel sequence, improv-
ing its representation of known human variation. The
most recent update to the reference genome was the
topic of a presentation by Valerie Schneider (National
Center for Biotechnology Information, USA).
We continue to accumulate vast amounts of biological
data. Integrating, storing and making this data available to
the research community were the focus of a database ses-
sion. Gary Saunders (European Bioinformatics Institute,
UK) presented Ensembl Variation, a repository of genetic
variation for all species. The Ensembl Regulation project,
described by Daniel Zerbino (European Bioinformatics
Institute, UK), annotates the human genome by collating
and integrating experimental data sets, such as ChIP-Seq,
DNase-Seq and transcription factor binding assays.
Emerging technology and new applications
of sequencing
The Oxford Nanopore MinION system was recently
made available through an early access program. As ex-
pected, there was much interest in hearing the experi-
ences of the laboratories participating in the program.
James Gurtowski (Cold Spring Harbor Laboratory, USA)
described their first few months with the system. Gurtowski
reported very long read lengths but with a high error rate
when compared to other platforms. However, Gurtowski
was able to generate a very contiguous assembly of
Saccharomyces cerevisiae when combining Oxford Nano-
pore reads with Illumina data. Nick Loman (Birmingham
University, UK) highlighted the small form-factor and low
cost of the MinION as key features. Loman presented
whole-genome data from Escherichia coli K-12 MG1655
generated on the MinION and discussed the effect of con-
trolling the rate of DNA translocation on read quality.
Loman also demonstrated the real-time functionality of
the MinION to identify bacterial strains in a recent hos-
pital outbreak. Species-level information could be recov-
ered within 20 minutes, serotyping within an hour, and
assignment to an outbreak cluster within 2 hours.
The Pacific Biosciences sequencing instrument, which
has become prominent for producing excellent assemblies
of numerous genomes, was used for two challenging se-
quencing projects. Samarth Rangavittal (Pennsylvania State
University, USA) assembled the gorilla Y chromosome
using PacBio data. Pin Tong (University of Edinburgh, UK)
applied PacBio sequencing to three Schizosaccharomyces
species to study centromere evolution in fission yeast.
Two talks presented unconventional applications of se-
quencing. Janet Kelso (Max Planck Institute for Evolution-
ary Anthropology, Germany) described how sequencing
ancient samples - Neanderthals in Europe and western
Asia, Denisovans in southern Siberia and a 45,000-year-
old modern human - provides insight into the relationship
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Darling (University of Technology Sydney, Australia)
has adopted the Hi-C protocol, which is typically used to
assay the three-dimensional structure of genomes, to im-
prove metagenomic assemblies. Metagenomic Hi-C pro-
vides information on which sequences are physically close
together in the sample; Darling demonstrated how this in-
formation can be used to group assembled contigs to-
gether into nearly complete species-level reconstructions.
This year’s edition of Genome Informatics highlighted
the rapid advances the community has made in applying
genomics in all areas of biology, and the increasing appli-
cations of sequencing towards questions of human health.
These advances are made possible by the development of
algorithms, software, instruments, databases and, crucially,
partnerships between biologists, clinicians and informati-
cians. Genome Informatics continues to bring these com-
munities together to explore the future of genomics as it
rapidly unfolds.
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